Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Binghao Li

Showing results (31-40 of 66) with videos related to

Pageof 7
Sort By:
Frontiers in Immunology|June 19, 2018
Decitabine Enhances Vγ9Vδ2 T Cell-Mediated Cytotoxic Effects on Osteosarcoma Cells <i>via</i> the NKG2DL-NKG2D AxisZhan Wang, Zenan Wang, Shu Li, et al.
Future Oncology (London, England)|June 30, 2026
VEBrant: a multicenter, phase II study of MET inhibitor vebreltinib combined with PD-1-based immunotherapy in advanced clear cell sarcomaYaling Jiang, Nong Lin, Xin Huang, et al.
Oncotarget|May 4, 2017
Pelvic reconstruction with different rod-screw systems following Enneking type I/I + IV resection: a clinical studyPeng Lin, Youyou Shao, Huigen Lu, et al.
International Orthopaedics|April 28, 2018
Bone combined cement grafting in giant cell tumor around the knee reduces mechanical failureWangsiyuan Teng, Peng Lin, Yong Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 14, 2024
First-Line Anlotinib Treatment for Soft-Tissue Sarcoma in Chemotherapy-Ineligible Patients: An Open-Label, Single-Arm, Phase 2 Clinical TrialTao Li, Ying Dong, Yongzhong Wei, et al.
Orthopaedic Surgery|July 20, 2024
Efficacy and Safety of Fruquintinib-Based Treatment in Patients with Refractory Bone and Soft Tissue Sarcoma after Developing Resistance to Several TKIs: A Multicenter Retrospective StudyChenchen Yang, Binghao Li, Sen Dong, et al.
Molecular Cancer|September 9, 2024
Phenotypic and spatial heterogeneity of CD8<sup>+</sup> tumour infiltrating lymphocytesYikan Sun, Eloy Yinwang, Shengdong Wang, et al.
Frontiers in Immunology|June 9, 2020
Th9 Cell Differentiation and Its Dual Effects in Tumor DevelopmentTao Chen, Jufeng Guo, Zhenhai Cai, et al.
Oncotarget|June 1, 2017
Three hematological indexes that may serve as prognostic indicators in patients with primary, high-grade, appendicular osteosarcomaKeqi Hu, Zhan Wang, Peng Lin, et al.
Frontiers in Immunology|March 15, 2018
Valproic Acid Combined with Zoledronate Enhance γδ T Cell-Mediated Cytotoxicity against Osteosarcoma Cells <i>via</i> the Accumulation of Mevalonate Pathway IntermediatesShengdong Wang, Hengyuan Li, Chenyi Ye, et al.
Pageof 7

Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Frontiers in Immunology|June 19, 2018
Decitabine Enhances Vγ9Vδ2 T Cell-Mediated Cytotoxic Effects on Osteosarcoma Cells <i>via</i> the NKG2DL-NKG2D AxisZhan Wang, Zenan Wang, Shu Li, et al.
Future Oncology (London, England)|June 30, 2026
VEBrant: a multicenter, phase II study of MET inhibitor vebreltinib combined with PD-1-based immunotherapy in advanced clear cell sarcomaYaling Jiang, Nong Lin, Xin Huang, et al.
Oncotarget|May 4, 2017
Pelvic reconstruction with different rod-screw systems following Enneking type I/I + IV resection: a clinical studyPeng Lin, Youyou Shao, Huigen Lu, et al.
International Orthopaedics|April 28, 2018
Bone combined cement grafting in giant cell tumor around the knee reduces mechanical failureWangsiyuan Teng, Peng Lin, Yong Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 14, 2024
First-Line Anlotinib Treatment for Soft-Tissue Sarcoma in Chemotherapy-Ineligible Patients: An Open-Label, Single-Arm, Phase 2 Clinical TrialTao Li, Ying Dong, Yongzhong Wei, et al.
Orthopaedic Surgery|July 20, 2024
Efficacy and Safety of Fruquintinib-Based Treatment in Patients with Refractory Bone and Soft Tissue Sarcoma after Developing Resistance to Several TKIs: A Multicenter Retrospective StudyChenchen Yang, Binghao Li, Sen Dong, et al.
Molecular Cancer|September 9, 2024
Phenotypic and spatial heterogeneity of CD8<sup>+</sup> tumour infiltrating lymphocytesYikan Sun, Eloy Yinwang, Shengdong Wang, et al.
Frontiers in Immunology|June 9, 2020
Th9 Cell Differentiation and Its Dual Effects in Tumor DevelopmentTao Chen, Jufeng Guo, Zhenhai Cai, et al.
Oncotarget|June 1, 2017
Three hematological indexes that may serve as prognostic indicators in patients with primary, high-grade, appendicular osteosarcomaKeqi Hu, Zhan Wang, Peng Lin, et al.
Frontiers in Immunology|March 15, 2018
Valproic Acid Combined with Zoledronate Enhance γδ T Cell-Mediated Cytotoxicity against Osteosarcoma Cells <i>via</i> the Accumulation of Mevalonate Pathway IntermediatesShengdong Wang, Hengyuan Li, Chenyi Ye, et al.
Pageof 7